7:00 am – 8:00 am
Product Theater: Patient Perspectives of Chronic Idiopathic/Spontaneous Urticaria: The Pathway Through Onset of Symptoms to Management
Continental Breakfast
Sponsored by Novartis (Medical Respiratory)
Michael Van Buren Calvin, MPAS, PA-C
Breckenridge
7:00 am – 8:00 am
Product Theater: Amzeeq™ (minocycline) topical foam, 4%: A New and Emerging Treatment Option
Sponsored by Foamix Pharma
Joe Gorelick, RN, MSN, FNP-C
Steamboat
8:00 am – 9:00 am
GS201/Robin Weber Immunology Symposium: Immunology: The Robin Weber Immunology Symposium (AANP)
This session is in tribute to one of DNA Past Presidents, Robin Weber, who had a passion for Immunology. Participants will be able to confidently identify the different clinical presentations of autoimmune disease.
Learning Objectives:
Describe clinical features of autoimmune disease.
Joann Zell, MD
Sabrina Newman, MD
Salon E
9:00 am – 10:30 am
Exhibit Open/Poster Viewing
Salon C & D
10:30 am – 11:00am
Opening Remarks
Diana Pencheva, FNP-BC, MSN, DCNP, NP Forum Chair
Salon B
11:00 am – 11:40 am
NP Business Meeting/Networking
Theresa Coyner, MSN, ANP-BC, DCNP
Katrina Masterson, DNP, RN, FNP-BC, DCNP
NPS Co-Chairs
Salon B
11:45 pm – 1:00pm
Lunch On Your Own
1:00 PM – 2:00 PM
NP224: Management Pearls in Adult Cutaneous Lupus Erythematosus and Dermatomyositis (AANP)
This presentation will provide practitioners of dermatology with important clinical information regarding the evaluation, diagnosis, work-up, and management of cutaneous lupus erythematosus and dermatomyositis in adult patients.
Learning Objectives:
Describe clinical exam features of cutaneous lupus and dermatomyositis.
Elizabeth B. Wallace, MD
Salon B
2:00 PM – 3:00 PM
NP Exhibits Open/Poster Viewing
Salon C & D
3:00 PM – 4:00 PM
NP234: Female Pattern Hair Loss (FPHL); Clinical Evaluation, Testing and Treatment (AANP)
Female pattern hair loss is a common “reason for visit” in dermatology. The visit can be a very emotional one for our patient due to the high sociocultural value of hair and hair care for many women. Efficient clinical evaluation and knowledgeable treatment are critical to quality treatment planning.
Learning Objectives:
Identify prudent clinical evaluation methods and testing for FPHL and develop a treatment plan appropriate for the patient.
Katrina Nice Masterson,DNP, RN, FNP-C, DCNP
Salon B
4:15 PM – 5:15 PM
NP244: Atopic Dermatitis (AANP)
Atopic dermatitis is a common skin disorder that is becoming more prevalent in the United States and in developing countries around the world. This multi-factorial disease affects adults as well as children. The clinical presentation and associated co-morbidities, such as infections and other types of dermatitis, are important to consider to optimize care of these patients. This presentation will focus on clinical aspects of atopic dermatitis in adults as well as preventive approaches and topical and systemic treatments for long-term management.
Learning Objectives:
Describe the diagnosis, treatment, and long-term management of adults with atopic dermatitis including use of topical corticosteroids, topical immunomodulators and short-course systemic corticorsteroids in extreme cases. Monitor patient on pharmcotherapy treatment knowing when to advance from topical agents and antibiotics for potential infections to systemic therapies including oral corticosteroids, cyclosporin, methotrexate and dupilumab identifying the pharmacokinetics and clinical application of each.
Cheryl Armstrong, MD
Salon B
5:15 pm – 6:15 pm
GS250: Legal Ramifications (AANP)
This presentation will focus on the essentials of medical malpractice as they apply to nursing and to nurse practitioners.
Learning Objectives:
Identify the basics of medical malpractice as it pertains to nursing.
Whitney High, MD, ID, MEng
Salon E
6:30 pm – 7:30 pm
Product Theater: TREMFYA®: A First-line Biologic with Clinical Data vs Adalimumab and vs Secukinumab Now with VOYAGE 1 Open-label Extension Data Through 4 Years
Wine and Cheese Served
Sponsored by Janssen
Kimberly M. Eads, MSN, FNP-BC, CCRP
Breckenridge
6:30 pm – 7:30 pm
Product Theater: QBREXZA (glycopyrronium)
Wine and Cheese Served
Sponsored by Dermira
Seemal R. Desai, MD, FAAD
Steamboat
8:00 pm – 10:00 pm
DNA After Dark with Nancy Norton Comedy Performance
Join your DNA colleagues at this evening comedy event. Nancy Norton is a former registered nurse who now chooses to heal with humor. She is a Nationally touring standup Comedian and Speaker who has been featured on A&E, PBS, and Amazon Prime. She is the 2018 winner of the Boston Comedy Festival and the ONLY woman to ever win the festival. Have fun with Nancy Norton!
Desserts and Cash Bar will be available
Salon E
7:00 am – 8:00 am
Continental Breakfast
Salon A
8:00 am – 9:00 am
GS301: What’s New in Dermatology Medications (AANP)
What’s New in Dermatology Medications – will provide an overview of new marketed medications, results of research studies regarding medications, and review new possible indications for older medications.
Learning Objectives:
Identify at least 3 new medications and/or new indications for older medications.
Theresa Coyner, MSN, RN, ANP-BC, DCNP
Salon E
9:15 AM – 10:15 AM
NP304: High Risk Systemic Medications Used in Dermatology (AANP)
This presentation will focus on systemic medications commonly used in dermatology. It will provide an overview of drug induced toxicity and recommendations for pre-treatment assessment and monitoring for drug induced side effects.
Learning Objectives:
Recognize potential mechanisms for drug induced toxicity. Select and interpret appropriate diagnostic testing for monitoring patients on systemic medication.
Sylvia Brice, MD
Salon B
10:15 AM – 11:15 AM
NP314: Autoimmune Blistering Disorders – Bullous Pemphigoid and Pemphigus Vulgaris (AANP)
To provide an overview of autoimmune blistering disorders, with a specific focus on bullous pemphigoid and pemphigus vulgaris, including appropriate evaluation and options for therapy.
Learning Objectives:
Differentiate clinical signs of bullous pemphigoid and pemphigus vulgaris.
Identity and interpret appropriate diagnostic testing.
Develop a plan for treatment appropriate to the individual patient and severity of disease.
Sylvia Brice, MD
Salon B
11:30 am – 1:00 pm
DNA Business Meeting and Luncheon
Join the DNA Leadership to discover our accomplishments over the past year as well as honor some of the finest DNA Volunteers and Award winners in our organization, and share in the goals of the upcoming year.
Salon E
1:00 PM – 2:00 PM
NP324: Kodachromes for Pediatric Cases (AANP)
Come and enjoy a visual compilation of pediatric dermatology cases. From viral exanthems to molluscum to psoriasis, learn about the different presentations you might encounter on the job.
Learning Objectives:
Identify common viral exanthems in children.
Victoria Garcia-Albea, MSN, NP, DCNP
Salon B
2:00 PM – 3:00 PM
NP334: Psoriatic Disease in 2020: Essential Updates (AANP)
This session will provide the essential psoriasis management updates that every dermatology nurse and advanced practice nurse needs to know. This includes an overview of the key clinical features of the various manifestations of psoriasis, newly identified comorbidities associated with psoriatic disease, and new treatment targets. The session will provide an interactive, case-based presentation that will ensure that you are up-to-date on your psoriatic disease knowledge.
Learning Objectives:
Identify 5 essential treatment targets for the treatment of psoriasis.
Lakshi Aldredge, MSN, ANP-BC, DCNP
Salon B
3:00 PM – 4:00 PM
NP344: Cutaneous T Cell Lymphoma/Mycosis Fungoides Update (AANP)
This activity is intended for healthcare professionals involved in the care of patients with Mycosis Fungoides – Cutaneous T Cell Lymphoma (MF-CTCL). The goal of this activity is to assess and summarize the current understanding of CTCL-MF in clinical practice.
Learning Objectives:
Assess and summarize the current understanding of CTCL-MF in clinical practice.
Theresa Pacheco, MD
Salon B
4:15 pm – 5:15 pm
GS350: Transgender Affirming Dermatological Care (AANP)
LGBTQ+ people have been historically marginalized and historically underserved in health care settings, including dermatology. Through affirming care trainings, Dermatological nurses can make an impact on reducing the frequent disrespect and harassment Transgender and Non-binary patients’ experiences accessing healthcare. This interactive workshop will be presentation-based with ample audience engagement and some space for discussion. Using a trauma informed care framework, we will review relevant terminology such as gender Identity and sex assigned at birth, discuss protocol on how to use and ask affirming name and pronouns, address binary forms such as IPLEDGE, how to ask for a patients affirming anatomical language, and general affirming practices and policy within dermatology settings.
Learning Objectives:
Identify three ways to increase Transgender and Nonbinary affirming practices within Dermatology.
Andrew Miller, MA
Salon E